← Back to Search

Traditional Chinese Medicine

Acupuncture for Breast Cancer Survivors

Phase 1

Recruiting

Research Sponsored by University of Illinois at Chicago

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Women with histologically confirmed stage 0, I, II, or III breast cancer

Self-reported pain, fatigue, sleep disturbance, depression, hot flashes and/or anxiety in the last month with an average severity rating ≥ 3 (0-10 numeric rating scale) for at least 3 of the 6 symptoms, and experience at least 2 physical symptoms (pain, fatigue, sleep disturbance)

Timeline

Screening 3 weeks

Treatment Varies

Follow Up through study completion, an average of 1 year

Awards & highlights

Study Summary

This trial tests if acupuncture can help breast cancer survivors improve their quality of life.

Who is the study for?

This trial is for English-speaking women over 18 who've had stage 0-III breast cancer, finished primary treatment within the last month, and are on endocrine therapy. They must have moderate to severe pain, fatigue, sleep issues, depression, hot flashes or anxiety. Excluded are those with bleeding disorders, inability to attend weekly acupuncture sessions, certain psychiatric or medical conditions that affect assessments (like dementia), and those pregnant or planning pregnancy.Check my eligibility

What is being tested?

The study is examining how feasible it is to include acupuncture as a regular treatment in health centers for breast cancer survivors dealing with symptoms like pain and fatigue after their main cancer treatments have ended.See study design

What are the potential side effects?

Acupuncture may cause minor side effects such as bruising at needle sites, light-headedness during treatment sessions. Serious side effects are rare but can include infections or injury if not performed correctly.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have been diagnosed with early-stage breast cancer.

Select...

I've had significant pain, fatigue, sleep issues, depression, hot flashes, or anxiety recently.

Select...

I finished my main cancer treatment last month and am now on hormone therapy.

Select...

I am 18 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ through study completion, an average of 1 year

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~through study completion, an average of 1 year

This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Acceptability for Treating Multiple Symptoms with Acupuncture

Identify barriers and facilitators associated with implementing acupuncture in federally qualified health center oncology clinics.

The numbers of study participants being recruited and retained (Feasibility)

Side effects data

From 2013 Phase 1 & 2 trial • 104 Patients • NCT01305811

Serious unexpected

Pain on needling

100%

80%

60%

40%

20%

Study treatment Arm

Bi-Weekly Acupuncture

Wait List

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Acupuncture groupExperimental Treatment1 Intervention

Participants will receive 2 acupuncture treatments each week for 5 weeks, for a total of 10 treatments. Each acupuncture treatment will take 30 minutes.

Group II: Usual care groupActive Control1 Intervention

Participants will continue to receive their usual care.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Acupuncture

2011

Completed Phase 3

~1240

0 / 4Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of Illinois at ChicagoLead Sponsor

609 Previous Clinical Trials

1,559,247 Total Patients Enrolled

10 Trials studying Breast Cancer

1,342,294 Patients Enrolled for Breast Cancer

Media Library

Acupuncture (Traditional Chinese Medicine) Clinical Trial Eligibility Overview. Trial Name: NCT05615753 — Phase 1

Breast Cancer Research Study Groups: Acupuncture group, Usual care group

Breast Cancer Clinical Trial 2023: Acupuncture Highlights & Side Effects. Trial Name: NCT05615753 — Phase 1

Acupuncture (Traditional Chinese Medicine) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05615753 — Phase 1

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What potential risks do individuals face when engaging in Acupuncture treatment?

"Although limited data exists to support the safety and efficacy of Acupuncture, our team at Power has assessed it as a score 1 on a scale from 1 to 3."

Answered by AI

How many participants are involved in the current clinical experiment?

"Affirmative. According to clinicaltrials.gov, the recruitment for this medical experiment is ongoing after it was first posted on 12th of January 2023 and revised most recently on 23rd March 2023. The trial requires 62 individuals from one site to participate."

Answered by AI

Is it still possible for participants to join this medical experiment?

"Affirmative, the information on clinicaltrials.gov affirmatively suggests that this trial is still recruiting patients. This study was first posted online in December 2023 and was revised in March of the same year. Currently, 62 individuals are being sought out from one medical centre to participate."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Feasibility of Implementing Acupuncture Into Federally Qualified Health Center Among Breast Cancer Survivors

Hongjin Li 2023. "Feasibility of Implementing Acupuncture Into Federally Qualified Health Center Among Breast Cancer Survivors". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05615753.